Healthcare resource utilization in first-line immunotherapies for patients with metastatic melanoma.

被引：0
|
作者：
Liu, Frank Xiaoqing
Klink, Andrew
Feinberg, Bruce A.
Ahsan, Sama
Nero, Damion
Chmielowski, Bartosz
机构：
[1] Merck & Co Inc, N Wales, PA USA
[2] Cardinal Hlth Specialty Solut, Dallas, TX USA
[3] Cardinal Hlth Specialty Solut, Dublin, OH USA
[4] Merck & Co Inc, Kenilworth, NJ USA
[5] Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 08期
关键词：
D O I：
10.1200/JCO.2019.37.8_suppl.137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页数：1
相关论文
共 50 条
  • [41] First-line treatment of NRAS-mutated metastatic melanoma with a MEK inhibitor
    Bickel, Angelika
    Diem, Stefan
    Flatz, Lukas
    Stinn, Bjorn
    Siano, Marco
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2021, 17 (01) : 276 - 278
  • [42] First-line biochemotherapy and high-dose IL-2 in biochemotherapy failures in metastatic melanoma. The hospital Sirio-Libanes experience
    Buzaid, A. C.
    Schmerling, R. A.
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 2007, 299 (5-6) : 303 - 304
  • [43] First-line treatment options for patients with metastatic colorectal cancer
    Richard L Schilsky
    [J]. Nature Clinical Practice Oncology, 2004, 1 : 70 - 71
  • [44] Healthcare resource utilization and costs associated with patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive NSCLC in the United States
    Samuelsen, Carl
    Lim, Jonathan
    Golembesky, Amanda
    Shrestha, Sulena
    Wang, Li
    Griebsch, Ingolf
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (01) : 48 - 53
  • [45] First-line treatment options for patients with metastatic colorectal cancer
    Schilsky, Richard L.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2004, 1 (02): : 70 - 71
  • [46] First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
    Bongiovanni, Alberto
    Riva, Nada
    Ricci, Marianna
    Liverani, Chiara
    La Manna, Federico
    De Vita, Alessandro
    Foca, Flavia
    Mercatali, Laura
    Severi, Stefano
    Amadori, Dino
    Ibrahim, Toni
    [J]. ONCOTARGETS AND THERAPY, 2015, 8 : 3613 - 3619
  • [47] Dacarbazine as First Line Treatment of Metastatic Melanoma in Elderly Patients
    Carneiro, F.
    Godinho, J.
    Sousa, N.
    Ferreira, P.
    Raimundo, A.
    Rodrigues, H.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S279 - S280
  • [48] Real-world healthcare resource utilization and costs in patients with chronic lymphocytic leukemia: differences between patients treated with first-line ibrutinib or bendamustine plus rituximab
    Irwin, Debra
    Wilson, Kathleen
    Thompson, Stephen
    Choudhry, Azhar
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (04) : 623 - 628
  • [49] First-line metastatic cancer of the colon
    Raoul, JL
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2003, 27 (05): : B150 - B153
  • [50] Surgery, radiation, and systemic therapies in patients with metastatic melanoma.
    Wang, Song
    Zhao, Zhongyun
    Barber, Beth
    Wagner, Volker Jean
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345